IDENTIFICATION OF POTENTIAL PHYTOCHEMICAL CANDIDATES FOR INHIBITION OF NLRP3 INFLAMMASOME IN DCM : AN IN-SILICO STUDY

Abstract

One of the most prevalent adverse consequences of diabetes is diabetic cardiomyopathy (DCM), which is also the leading cause of death in people with diabetes. This disease was discovered in 1972 and has been the subject of research ever since. Over the past ten years, extensive research has been done on the pathophysiology and clinical characteristics of diabetic cardiomyopathy, but there are currently few proven methods for its prevention and treatment. Basically, DCM occurs because of the unregulated metabolic pathways associated with diabetes, which further result in high oxidative stress along with onset of many inflammatory pathways which can lead to Heart Failure. In some studies, it has been revealed that there are some agents that when focused upon, can be possible cardio protective approaches to prevent the condition. This dissertation goes into detail about a one such agent i.e. NLRP3. Several computational tools, including Autodock Vina, Pymol, Protein Drug Bank, and PILP, are used in this study. (Protein-Interaction Ligand Profiler). By using PILP and molecular docking of the protein and ligand, the interactions between NLRP3 and plant phytochemicals are investigated. Drug discovery is facilitated by research into protein and ligand inter-connection. The purpose of this intense examination is to identify the most effective plant phytochemicals that have demonstrated promise in preventing DCM in humans.